Back to Search Start Over

Pharmacological Profiling of Orthochirus scrobiculosus Toxin 1 Analogs with a Trimmed N-Terminal Domain

Authors :
Heike Wulff
Yingliang Wu
Violeta Visan
Stéphanie Mouhat
Michel De Waard
Stephan Grissmer
Daniel Homerick
Hervé Darbon
Jean-Marc Sabatier
Georgeta Teodorescu
Canepari, Marco
Laboratoire Cellpep S.A.
Ingénierie des protéines (IP)
Université de la Méditerranée - Aix-Marseille 2-Centre National de la Recherche Scientifique (CNRS)
Universität Ulm - Ulm University [Ulm, Allemagne]
Department of Medical Pharmacology and Toxicology
University of California [Davis] (UC Davis)
University of California (UC)-University of California (UC)
College of Life Sciences
Wuhan University [China]
Architecture et fonction des macromolécules biologiques (AFMB)
Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)
Canaux calciques , fonctions et pathologies
Université Joseph Fourier - Grenoble 1 (UJF)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Collaboration
University of California-University of California
Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)
Source :
Molecular Pharmacology, Molecular Pharmacology, 2006, 69 (1), pp.354-62. ⟨10.1124/mol.105.017210⟩, Molecular Pharmacology, American Society for Pharmacology and Experimental Therapeutics, 2006, 69 (1), pp.354-62. ⟨10.1124/mol.105.017210⟩
Publication Year :
2005
Publisher :
American Society for Pharmacology & Experimental Therapeutics (ASPET), 2005.

Abstract

International audience; OSK1, a toxin from the venom of the Asian scorpion Orthochirus scrobiculosus, is a 38-residue peptide cross-linked by three disulfide bridges. A structural analog of OSK1, [Lys(16),Asp(20)]-OSK1, was found previously to be one of the most potent blockers of the voltage-gated K(+) channel Kv1.3 hitherto characterized. Here, we demonstrate that progressive trimming of the N-terminal domain of [Lys(16),Asp(20)]-OSK1 results in marked changes in its pharmacological profile, in terms of both K(+) channel affinity and selectivity. Whereas the affinity to Kv1.1 and Kv1.3 did not change significantly, the affinity to Kv1.2 and K(Ca)3.1 was drastically reduced with the truncations. It is surprising that a striking gain in potency was observed for Kv3.2. In contrast, a truncation of the C-terminal domain, expected to partially disrupt the toxin beta-sheet structure, resulted in a significant decrease or a complete loss of activity on all channel types tested. These data highlight the value of structure-function studies on the extended N-terminal domain of [Lys(16),Asp(20)]-OSK1 to identify new analogs with unique pharmacological properties.

Details

ISSN :
15210111 and 0026895X
Volume :
69
Database :
OpenAIRE
Journal :
Molecular Pharmacology
Accession number :
edsair.doi.dedup.....cfdc8553ff6b630a7906071fac25fe10
Full Text :
https://doi.org/10.1124/mol.105.017210